New Study Reveals Therapeutic Cannabis Benefits for Medical Conditions, with 96% Reporting Positive Effects

Introduction:

A recent comprehensive study conducted by researchers from the University of Otago, Victoria University, and the University of Auckland has shed light on the therapeutic benefits of cannabis. The study involved 213 individuals who were using cannabis for therapeutic purposes. By exploring the experiences and effects of cannabis as a treatment option, the researchers aimed to gather valuable data on its quality, efficacy, and impact on participants.

Improvement in Medical Conditions:

The study's findings were remarkable, with nearly 96% of participants reporting improvements in their medical conditions as a result of therapeutic cannabis usage. Furthermore, 46% of respondents revealed that they were able to either reduce or completely cease their previously prescribed medications. The most prevalent benefits were observed in pain management, where 96% of participants experienced positive effects. Additionally, cannabis aided 97% of participants with sleep difficulties and 98% with mental health issues.

Effectiveness for Various Conditions:

Among the participants who used cannabis for conditions such as autism, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), and eating difficulties, an impressive 98% reported positive effects.

Reduced Dependence on Opioids:

Dr. Geoff Noller, a co-author of the study from the Dunedin School of Medicine's bioethics department, highlighted a significant finding. Some participants were able to decrease or discontinue their use of prescribed medications, many of which were opioid-based. This not only demonstrated the tangible benefits experienced through cannabis usage but also indicated a reduction in the reliance on potentially problematic medications. Opioids, known for their adverse side effects and dependency issues, were among the drugs reduced or eliminated by participants.

Complementary Approach:

Dr. Noller emphasized that the study's results did not imply a complete replacement of prescribed medicines with cannabis. Instead, he suggested that there is room for both approaches, as cannabis products could play a role in treating patients with chronic pain and other conditions that are resistant to conventional treatment methods.

Barriers and Recommendations:

One significant barrier identified by the study was the majority of participants resorting to illicit means to source cannabis due to limitations in accessing it legally. Dr. Noller highlighted two key obstacles: cost and lack of physician knowledge. The high prices of currently available medicinal cannabis products, attributed to compliance costs imposed by regulations, made them unaffordable for many New Zealanders. Additionally, a lack of awareness among physicians led to hesitation in prescribing cannabis-based treatments.

Benefits for Patients and Recommendations for Future Action:

The study's results not only affirm previous research conducted in Aotearoa but also highlight the need for action to address the barriers hindering access to therapeutic cannabis. The following sections outline the benefits for patients and provide recommendations for future steps.

Patient Benefits:

a. Enhanced Pain Management: The study revealed that therapeutic cannabis was highly effective in managing pain, with 96% of participants reporting positive outcomes. This could be a significant breakthrough for individuals suffering from chronic pain conditions.

b. Improved Sleep Quality: Nearly all participants (97%) experienced improvements in sleep difficulties when using cannabis therapeutically. Addressing sleep disorders is crucial for overall well-being and quality of life.

c. Mental Health Support: The study demonstrated that therapeutic cannabis provided relief for 98% of participants with mental health issues. This highlights its potential as an alternative or complementary treatment option for anxiety, depression, and other mental health conditions.

Recommendations for Action:

a. Access and Affordability: Current regulations surrounding medicinal cannabis have created significant barriers for patients. The high cost of production compliance has resulted in expensive products, limiting access for many New Zealanders. Regulatory authorities should explore ways to reduce costs and improve affordability to ensure that therapeutic cannabis is accessible to those who need it.

b. Physician Education and Awareness: The lack of knowledge among physicians regarding cannabis-based treatments poses a challenge. Educating healthcare professionals about the potential benefits, appropriate usage, and dosage guidelines for therapeutic cannabis is essential. This will help foster informed discussions and enable physicians to make informed decisions when considering cannabis as a treatment option.

c. Streamlined Regulations: To facilitate access to therapeutic cannabis, regulations should be reviewed and potentially streamlined. Simplifying the process for prescribing and obtaining cannabis-based treatments can reduce barriers and ensure timely access for patients.

d. Research and Development: Continued research into the therapeutic benefits of cannabis is crucial. Further studies should explore different strains, formulations, and delivery methods to optimize efficacy and minimize potential side effects. Additionally, long-term studies assessing the safety and effectiveness of cannabis-based treatments will provide valuable insights for healthcare professionals and patients.

Conclusion:

The recent study on therapeutic cannabis conducted by researchers from the University of Otago, Victoria University, and the University of Auckland has provided compelling evidence of its positive effects in improving medical conditions. With an overwhelming majority of participants reporting benefits in pain management, sleep difficulties, and mental health, it is clear that therapeutic cannabis has the potential to be a valuable treatment option. However, addressing barriers to access, improving physician education, streamlining regulations, and promoting further research are essential steps to ensure that patients can benefit from therapeutic cannabis in a safe and regulated manner. By taking these actions, New Zealand can harness the potential of cannabis as a complementary approach to conventional treatments, providing relief and improved quality of life for those with chronic conditions.

References:

(https://www.newshub.co.nz/home/new-zealand/2023/05/new-study-into-therapeutic-cannabis-finds-96pct-of-participants-report-benefits-in-medical-conditions.html)